InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Imran Talat, Chairman & CEO. Insider active across 1 companies, notably Rani Therapeutics Holdings, Inc.. Aggregated, 3 filings have been logged. The latest transaction was filed on 22 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations3 total
086,600 shares0
Class A Common Stock
SEC:0001209191-22-021022:0·
0827,467 shares0
Class A Common Stock
SEC:0001209191-22-007647·
0827,467 shares0
Class A Common Stock
SEC:0001209191-22-007647:0·
3 of 3 declarations
About Imran Talat
Talat Imran is the Chief Executive Officer of Rani Therapeutics Holdings, Inc. He leads the company with a focus on innovation in the biotechnology field. His strategic leadership aims to develop advanced therapeutic solutions to improve patient health.
